Skip to content

Treatment of vomiting in pregnancy by Ayurveda

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF CHHARDIRIPU VATI IN THE MANAGEMENT OF GARBHINI CHHARDI

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/03/008138
Enrollment
40
Registered
2017-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Garbhini Chhardi

Interventions

Intervention1: Chhardiripu Vati: Dose-2 tablets(500mg each) Two times a day Duration-14 days Control Intervention1: Tablet Doxylamine succinate(10) with pyridoxine hydrochloride(10): Dose-1 tablet (20

Sponsors

Parul Institute of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Antenatal patient with complain of Chhardi and hrullas(nausea and vomiting). 2.Patient between 20-35 years of age. 3.Patients of 1st and 2nd trimester of pregnancy. 4.Primigravida. 5.Willing and cooperative patient.

Exclusion criteria

Exclusion criteria: 1.Patient with Hyperemesis gravidarum. 2.Patients of 3rd trimester of pregnancy. 3.Pregnant Patients with communicable disease, other systemic disorders like appendicitis, Hepatitis, Gestational Diabetes, Gestational Hypertension etc. 4.Pregnant Patients with molar pregnancy, ectopic pregnancy and multiple pregnancies

Design outcomes

Primary

MeasureTime frame
Changes in PUQE-24(Pregnancy Unique Quantification of emesis) ScaleTimepoint: Changes in PUQE-24(Pregnancy Unique Quantification of emesis) Scale in 14 days

Secondary

MeasureTime frame
Changes in PUQE-24(pregnancy unique quantification of emesis) scaleTimepoint: Changes in PUQE-24(pregnancy unique quantification of emesis)scale in 14 days

Countries

India

Contacts

Public ContactDivyakumari Solanki

Gujarat ayurved university,Jamnagar

ritamakim@gmail.com9427538404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026